Related references
Note: Only part of the references are listed.Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes
Yasunobu Nagata et al.
BLOOD (2020)
NPM1-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
Fabio Forghieri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes
Yasunobu Nagata et al.
NATURE COMMUNICATIONS (2019)
Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms
Sanjay S. Patel et al.
BLOOD ADVANCES (2019)
NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy
Guillermo Montalban-Bravo et al.
BLOOD ADVANCES (2019)
High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML
Sanjay S. Patel et al.
BLOOD (2018)
Consequences of mutant TET2 on clonality and subclonal hierarchy
Cassandra M. Hirsch et al.
LEUKEMIA (2018)
The clonal origins of leukemic progression of myelodysplasia
T. Kim et al.
LEUKEMIA (2017)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
Fabio Forghieri et al.
LEUKEMIA & LYMPHOMA (2015)
FLT3 and NPM1 Mutations in Myelodysplastic Syndromes Frequency and Potential Value for Predicting Progression to Acute Myeloid Leukemia
Ashish Bains et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms
S. Schnittger et al.
LEUKEMIA (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias
Alicja M. Gruszka et al.
BLOOD (2010)
Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML
F. Dicker et al.
LEUKEMIA (2010)
Cytoplasmic Localization of Nucleophosmin in Bone Marrow Blasts of Acute Myeloid Leukemia Patients Is Not Completely Concordant With NPM1 Mutation and Is Not Predictive of Prognosis
Sergej Konoplev et al.
CANCER (2009)
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features
Brunangelo Falini et al.
BLOOD (2007)
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia
Brunangelo Falini et al.
BLOOD (2006)
Nucleophosmin is essential for ribosomal protein L5 nuclear export
Yue Yu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
B Falini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis
KQ Ye
CANCER BIOLOGY & THERAPY (2005)
The role of nucleophosmin in centrosome duplication
M Okuda
ONCOGENE (2002)
Share Paper
